| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 10/17/2006 | CA2324919C Hiv inhibiting pyrimidine derivatives |
| 10/17/2006 | CA2275686C Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| 10/17/2006 | CA2260065C Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 10/17/2006 | CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists |
| 10/17/2006 | CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 10/17/2006 | CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 10/17/2006 | CA2197207C Hiv protease inhibitor combination |
| 10/12/2006 | WO2006108107A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/12/2006 | WO2006108059A1 C-met modulators and methods of use |
| 10/12/2006 | WO2006107923A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases |
| 10/12/2006 | WO2006107661A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 10/12/2006 | WO2006107059A1 Medicine for renal perfusion disorder |
| 10/12/2006 | WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group |
| 10/12/2006 | WO2006106812A1 Propane-1,3-dion derivative or salt thereof |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106711A1 Antifungal agent containing pyridine derivative |
| 10/12/2006 | WO2006106425A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | WO2006106423A2 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 10/12/2006 | WO2006106416A1 PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN |
| 10/12/2006 | WO2006106326A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/12/2006 | WO2006106052A1 Pyrazoles |
| 10/12/2006 | WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | WO2006105862A1 Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
| 10/12/2006 | WO2006105844A1 Pyrazole derivatives |
| 10/12/2006 | WO2006105796A1 Novel indolinone derivatives |
| 10/12/2006 | WO2006105795A1 Novel indolinone derivatives |
| 10/12/2006 | WO2006082412A3 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 10/12/2006 | WO2006078283A3 Quinoxaline inhibitors of hedgehog signalling |
| 10/12/2006 | WO2006066879A3 Compounds with kv4 ion channel activity |
| 10/12/2006 | WO2006064351A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 10/12/2006 | WO2006018220A3 Method for the production of dihydropteridinones |
| 10/12/2006 | WO2006010591A3 Quinazoline derivatives |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | WO2005023760A3 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 10/12/2006 | US20060229342 TNF-a production inhibitors |
| 10/12/2006 | US20060229338 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 10/12/2006 | US20060229337 Certain substituted amides, method of making, and method of use thereof |
| 10/12/2006 | US20060229335 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| 10/12/2006 | US20060229334 Biphenyl derivatives |
| 10/12/2006 | US20060229330 4-aminopyrimidine-5-one derivatives |
| 10/12/2006 | US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/12/2006 | US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 10/12/2006 | US20060229312 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 10/12/2006 | US20060229311 Isatine derivatives with neurotrophic activity |
| 10/12/2006 | US20060229308 Substituted pyrirmidin-4-ylamine analogues as vanilloid receptor ligands |
| 10/12/2006 | US20060229307 partial antagonists and partial agonists of vanilloid-1 receptor (VR1); N-(4-trifluoromethylphenyl)-2-(3-trifluoromethyl-2-pyridinyl)pyrido[2,3-d]pyridazin-5-amine; antiinflammatory and analgesic agent |
| 10/12/2006 | US20060229300 Method for the preparation of enantiomerically pure mirtazapine |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | US20060229205 Herbicidal heterocycles |
| 10/12/2006 | CA2603939A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | CA2603748A1 C-met modulators and methods of use |
| 10/12/2006 | CA2603472A1 Pyrazole derivatives |
| 10/12/2006 | CA2603398A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | CA2603304A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases |
| 10/12/2006 | CA2603250A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/12/2006 | CA2603169A1 Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
| 10/12/2006 | CA2602467A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | CA2602234A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 10/12/2006 | CA2601983A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/11/2006 | EP1710243A1 Therapeutic agent for vasospasm accompanying bypass operation |
| 10/11/2006 | EP1710242A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha levels |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1709965A2 Methods of treating cytokine mediate diseases |
| 10/11/2006 | EP1709037A2 Hiv protease inhibiting sulfonamides |
| 10/11/2006 | EP1709030A1 Indolylmaleimide derivatives |
| 10/11/2006 | EP1709029A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 10/11/2006 | EP1709028A1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors |
| 10/11/2006 | EP1709012A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors |
| 10/11/2006 | EP1709011A1 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 10/11/2006 | EP1709009A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 10/11/2006 | EP1709006A1 Benzimidazole derivatives |
| 10/11/2006 | EP1708996A1 Fused heteroyral derivatives for use as p38 kinase inhibitors |
| 10/11/2006 | EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 10/11/2006 | EP1708718A1 Triazole derivatives which inhibit vasopressin antagonistic activity |
| 10/11/2006 | EP1708704A2 4-aryl piperidines |
| 10/11/2006 | EP1708703A2 Chemokine receptor binding compounds |
| 10/11/2006 | EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 10/11/2006 | EP1708701A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 10/11/2006 | EP1708699A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- k .b activity and use thereof |
| 10/11/2006 | EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 10/11/2006 | EP1708697A2 Chemical compounds |
| 10/11/2006 | EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 10/11/2006 | EP1529041B1 Novel prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, production and use thereof as medicaments |
| 10/11/2006 | EP1469851B1 Melanocortin receptor agonists |
| 10/11/2006 | EP1363903B1 Indole derivatives and their use as gnrh antagonists |
| 10/11/2006 | EP1306375B1 Salts of benzimidazole compound and application thereof |
| 10/11/2006 | EP1107959B1 Quinazoline derivatives as medicaments |
| 10/11/2006 | EP0944619B1 Novel integrin receptor antagonists |
| 10/11/2006 | CN1845924A Arylamine-substituted quinazolinone compounds |
| 10/11/2006 | CN1845922A Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 10/11/2006 | CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors |
| 10/11/2006 | CN1845920A 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 10/11/2006 | CN1845919A 3-pyridylcarboxamide derivatives as pesticidal agents |
| 10/11/2006 | CN1845918A Pyrimidines useful as modulators of voltage-gated ion channels |
| 10/11/2006 | CN1845917A 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicam |
| 10/11/2006 | CN1845916A 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 10/11/2006 | CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 10/11/2006 | CN1845908A 5-substituted quinazolinone derivatives |
| 10/11/2006 | CN1845904A Ophthalmic compositions for treating ocular hypertension |
| 10/11/2006 | CN1845903A Pesticides |